Search

everythinglearnresearchcommunity

for

Search:↓

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

Melatonin may help treat PCOS symptoms in rats.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

The conclusion is that there's no significant link between male pattern baldness and the severity of coronary artery disease.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

Darkened knuckles can be an early sign of insulin resistance.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Many women with PCOS have hair loss, linked to age, hirsutism, sleep issues, and smoking.

Premature graying of hair is linked to vitamin D and B12 deficiencies, thyroid issues, iron imbalance, stress, and lifestyle habits, and affects quality of life.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

Men with male pattern baldness may have a higher risk of heart disease due to increased levels of a specific lipid in their blood.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Various treatments exist for hair loss, but more research is needed for better options.

Experts created guidelines for treating hair loss in Egypt, focusing on personalized care.

Vegetarians should take B vitamin supplements to avoid health issues.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.